ID: ALA5171551

Max Phase: Preclinical

Molecular Formula: C38H65N13O8S2

Molecular Weight: 896.15

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@@H](CCSSCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O

Standard InChI:  InChI=1S/C38H65N13O8S2/c1-22(2)20-29(36(58)59)50-32(54)26(13-18-60-61-19-14-39)47-33(55)28(21-23-9-11-24(52)12-10-23)49-34(56)30-8-5-17-51(30)35(57)27(7-4-16-46-38(43)44)48-31(53)25(40)6-3-15-45-37(41)42/h9-12,22,25-30,52H,3-8,13-21,39-40H2,1-2H3,(H,47,55)(H,48,53)(H,49,56)(H,50,54)(H,58,59)(H4,41,42,45)(H4,43,44,46)/t25-,26+,27-,28-,29-,30-/m0/s1

Standard InChI Key:  GJIFCEKRNNRBMK-CEIPDFQMSA-N

Associated Targets(Human)

Neurotensin receptor 1 1525 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurotensin receptor 2 296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 896.15Molecular Weight (Monoisotopic): 895.4520AlogP: -1.42#Rotatable Bonds: 28
Polar Surface Area: 370.08Molecular Species: ZWITTERIONHBA: 13HBD: 14
#RO5 Violations: 3HBA (Lipinski): 21HBD (Lipinski): 18#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.77CX Basic pKa: 11.68CX LogP: -6.25CX LogD: -9.11
Aromatic Rings: 1Heavy Atoms: 61QED Weighted: 0.02Np Likeness Score: 0.12

References

1. Einsiedel J, Schmidt MF, Hübner H, Gmeiner P..  (2022)  Development of disulfide-functionalized peptides covalently binding G protein-coupled receptors.,  61  [PMID:35334449] [10.1016/j.bmc.2022.116720]

Source